Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059156) titled 'Effects of the intake of test product on skin condition' on Oct. 1.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Showa Women's University
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Evaluate the effects of the test product on the skin function.
Basic objectives2 - Safety,Efficacy
Intervention:
Interventions/Control_1 - Intake the test product for 6 weeks.
Interventions/Control_2 - Intake the placebo product for 6 weeks.
Eligibility:
Age-lower limit - 18
years-old
Gender - Female
Key inclusion criteria - 1.Healthy female adults who are aged between 18 and 24 years at the time of informed consent.
2.Those who received the sufficient explanation for the objective and summary of the trial, voluntarily decided to participate in the trial after understanding the purpose, and made the written agreement.
Key exclusion criteria - Subjects --
1.who are currently undergoing medical treatment by doctor and using medication.
2.judged by the principal investigator to be unsuitable for this study.
Target Size - 30
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 01 Day
Date of IRB - 2025 Year 07 Month 10 Day
Anticipated trial start date - 2025 Year 10 Month 04 Day
Last follow-up date - 2027 Year 10 Month 01 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067669
Disclaimer: Curated by HT Syndication.
